Iridex (IRIX) Net Margin (2010 - 2026)
Iridex's quarterly Net Margin came in at 4.44% in Q2 2026, up 973.0% year-on-year from 0.41% in Q2 2025, and up 23.43% quarter-over-quarter from 5.8% in Q1 2026.
Iridex has reported Net Margin for 17 years, with the latest figure at 4.44% in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 973.0% year-over-year to 4.44%; the trailing twelve-month figure through Apr 2026 stood at 7.5% (down 1068.0% YoY), and the FY2026 full-year result was 9.7%, down 923.0% from the prior year.
- Net Margin for Q2 2026 stood at 4.44%, up from 5.8% in the prior quarter.
- The five-year high for Net Margin was 61.81% in Q4 2024, with the low at 29.45% in Q1 2024.
- Average Net Margin over 5 years is 5.42%, with a median of 13.12% recorded in 2023.
- Year-over-year, Net Margin soared 6186 bps in 2023 and tumbled 6761 bps in 2026.
- Tracing IRIX's Net Margin over 5 years: stood at 7.96% in 2022, then surged by 777 bps to 53.89% in 2023, then gained by 15 bps to 61.81% in 2024, then plunged by 120 bps to 12.6% in 2025, then soared by 65 bps to 4.44% in 2026.
- The last three Net Margin figures came in at 4.44% (Q2 2026), 5.8% (Q1 2026), and 12.6% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | -4.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -4.44% |
| Jan 3, 2026 | 33.05% |
| Sep 27, 2025 | -12.60% |
| Jun 28, 2025 | -7.32% |
| Mar 29, 2025 | -14.17% |
| Dec 28, 2024 | 61.81% |
| Sep 28, 2024 | -16.69% |
| Jun 29, 2024 | -21.21% |
| Mar 30, 2024 | -29.45% |
| Dec 30, 2023 | 53.89% |
| Sep 30, 2023 | -13.65% |
| Jul 1, 2023 | -21.52% |
| Apr 1, 2023 | -15.25% |
| Dec 31, 2022 | -7.96% |
| Oct 1, 2022 | -12.07% |
| Jul 2, 2022 | -16.29% |
| Apr 2, 2022 | -17.86% |
| Jan 1, 2022 | 20.63% |
| Oct 2, 2021 | -16.32% |
| Jul 3, 2021 | 10.38% |
| Apr 3, 2021 | -16.81% |
| Sep 26, 2020 | -19.53% |
| Jun 27, 2020 | -44.70% |
| Mar 28, 2020 | -18.30% |
| Dec 28, 2019 | 60.81% |
| Sep 28, 2019 | -16.74% |
| Jun 29, 2019 | -23.20% |
| Mar 30, 2019 | -28.77% |
| Dec 29, 2018 | 85.59% |
| Sep 29, 2018 | -27.16% |
| Jun 30, 2018 | -31.83% |
| Mar 31, 2018 | -37.89% |
| Dec 30, 2017 | -50.33% |
| Sep 30, 2017 | -28.50% |
| Jul 1, 2017 | -27.49% |
| Apr 1, 2017 | -17.80% |
| Dec 31, 2016 | -86.31% |
| Oct 1, 2016 | -6.85% |
| Jul 2, 2016 | -2.75% |
| Apr 2, 2016 | 0.85% |
| Jan 2, 2016 | -7.46% |
| Oct 3, 2015 | 4.50% |
| Jul 4, 2015 | -7.22% |
| Apr 4, 2015 | 2.28% |
| Sep 27, 2014 | 4.84% |
| Jun 28, 2014 | 2.80% |
| Mar 29, 2014 | 4.71% |
| Dec 28, 2013 | 3.89% |
| Dec 29, 2012 | 24.76% |
| Sep 29, 2012 | -2.41% |
| Mar 31, 2012 | -1.95% |
| Dec 31, 2011 | 2.10% |
| Jul 2, 2011 | 0.36% |
| Oct 2, 2010 | 43.79% |
| Jul 3, 2010 | 10.43% |